MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression
Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression
Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression
Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression
Journal Article

Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progression

2025
Request Book From Autostore and Choose the Collection Method
Overview
Hepatitis B virus (HBV)-related liver cirrhosis (HBV-LC) is a significant global health issue, affecting gut microbiota (GM) composition and metabolic processes. This study aimed to explore the associations between intestinal microbiota, metabolic profiles, and disease progression in patients with HBV-LC. Fecal samples were collected prospectively from 40 healthy controls (HC) and 83 HBV-LC patients between December 2022 and August 2023. Gut microbiota alterations at various stages of liver function were analyzed using 16S rRNA gene sequencing. Untargeted metabolomics was employed to identify potential biomarkers and metabolic pathways associated with early cirrhosis. Additionally, correlations between bacterial genera, inflammatory markers, and metabolites were investigated. HBV-LC patients demonstrated a significant reduction in bacterial diversity and relative abundance compared to the HC group. Genera such as and were notably depleted, while and were enriched in patients with Model for End-Stage Liver Disease (MELD) scores ≥ 21 or Child-Turcotte-Pugh C grade. Correlation analyses revealed strong associations between intestinal flora, clinical indicators of disease severity, and inflammatory factors. Metabolic analysis showed decreased levels of tocopherol and 21-hydroxypregnenolone, which were strongly linked to the reduced abundance of and . Biosynthesis of unsaturated fatty acids and linoleic acid metabolism emerged as critical enrichment pathways. HBV-LC patients displayed significant alterations in gut microbiota and fecal metabolites, which correlated closely with disease severity and inflammatory status. These findings provide new insights into cirrhosis pathogenesis and suggest potential biomarkers for early diagnosis and disease monitoring.